Journal
JOURNALS OF GERONTOLOGY SERIES A-BIOLOGICAL SCIENCES AND MEDICAL SCIENCES
Volume 61, Issue 2, Pages 115-124Publisher
OXFORD UNIV PRESS INC
DOI: 10.1093/gerona/61.2.115
Keywords
-
Categories
Funding
- NIAMS NIH HHS [AR42525] Funding Source: Medline
- NIA NIH HHS [AG13282] Funding Source: Medline
- NIDDK NIH HHS [DK49730, DK42111] Funding Source: Medline
Ask authors/readers for more resources
We previously reported that heterozygous DNA methyltransferase 1-deficient (Dnmt 1(+/-)) mice maintain T-cell immune function and DNA methylation levels with aging. whereas controls develop autoimmunity, immune senescence, and DNA hypomethylation. We therefore compared survival, cause of death, and T-cell DNA methylation gene expression during aging ill Dnmt 1(+/-) mice and controls. No difference in longevity was observed, but greater numbers of Dnmt 1(+/-) mice developed jejunal apolipoprotein All amyloidosis. Both groups showed decreased Dnmt 1 expression with aging. However, expression of the de novo methyltransferases Dnmt3a and Dnmt3b increased with aging in stimulated T cells from control mice. MeCP2, a methylcytosine binding protein that participates in maintenance DNA methylation, increased with age in Dnmt 1(+/-) mice, suggesting a mechanism for the sustained DNA methylation levels. This model thus provides potential mechanisms for DNA methylation changes of aging, and suggests that changes in DNA methylation may contribute to some forms of amyloidosis that develop with aging.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available